Rep. Byron Donalds Sells Off Shares of Chemed Co. (NYSE:CHE)

Representative Byron Donalds (R-Florida) recently sold shares of Chemed Co. (NYSE:CHE). In a filing disclosed on April 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in Chemed stock on March 6th. The trade occurred in the Representative’s “MORAN WEALTH IRA” account.

Representative Byron Donalds also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of DoorDash (NASDAQ:DASH) on 3/20/2025.
• Sold $1,001 – $15,000 in shares of GoDaddy (NYSE:GDDY) on 3/20/2025.
• Purchased $1,001 – $15,000 in shares of Arista Networks (NYSE:ANET) on 3/20/2025.
• Sold $1,001 – $15,000 in shares of Robinhood Markets (NASDAQ:HOOD) on 3/20/2025.
• Purchased $1,001 – $15,000 in shares of Abbott Laboratories (NYSE:ABT) on 3/20/2025.
• Sold $1,001 – $15,000 in shares of Gartner (NYSE:IT) on 3/20/2025.
• Purchased $1,001 – $15,000 in shares of Chipotle Mexican Grill (NYSE:CMG) on 3/20/2025.
• Sold $1,001 – $15,000 in shares of Equifax (NYSE:EFX) on 3/20/2025.
• Purchased $1,001 – $15,000 in shares of Tradeweb Markets (NASDAQ:TW) on 3/20/2025.
• Sold $1,001 – $15,000 in shares of JPMorgan Chase & Co. (NYSE:JPM) on 3/20/2025.

Chemed Trading Down 0.1 %

NYSE:CHE traded down $0.86 on Thursday, reaching $580.52. 110,655 shares of the stock traded hands, compared to its average volume of 97,664. The company has a market capitalization of $8.48 billion, a price-to-earnings ratio of 29.33, a PEG ratio of 2.15 and a beta of 0.49. The company’s fifty day simple moving average is $585.24 and its 200 day simple moving average is $567.97. Chemed Co. has a 12 month low of $512.12 and a 12 month high of $623.61.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. Chemed’s payout ratio is 10.05%.

Hedge Funds Weigh In On Chemed

A number of large investors have recently bought and sold shares of the business. Hanson & Doremus Investment Management grew its holdings in Chemed by 14.3% during the 1st quarter. Hanson & Doremus Investment Management now owns 3,493 shares of the company’s stock worth $2,149,000 after acquiring an additional 437 shares in the last quarter. Everpar Advisors LLC raised its stake in shares of Chemed by 9.0% in the first quarter. Everpar Advisors LLC now owns 485 shares of the company’s stock worth $298,000 after purchasing an additional 40 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in Chemed by 8.2% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 1,496 shares of the company’s stock valued at $921,000 after acquiring an additional 114 shares during the period. Net Worth Advisory Group raised its stake in shares of Chemed by 18.1% during the 1st quarter. Net Worth Advisory Group now owns 541 shares of the company’s stock valued at $333,000 after buying an additional 83 shares during the last quarter. Finally, SG Americas Securities LLC acquired a new stake in Chemed during the first quarter worth about $1,250,000. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insider Buying and Selling at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the transaction, the chief executive officer now owns 102,679 shares of the company’s stock, valued at $60,957,441.93. This represents a 1.91 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 3.32% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

CHE has been the subject of a number of research reports. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Royal Bank of Canada increased their target price on Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research report on Friday, March 14th.

About Representative Donalds

Byron Donalds (Republican Party) is a member of the U.S. House, representing Florida’s 19th Congressional District. He assumed office on January 3, 2021. His current term ends on January 3, 2027.

Donalds (Republican Party) is running for re-election to the U.S. House to represent Florida’s 19th Congressional District. He declared candidacy for the 2026 election.

Byron Donalds was born in Brooklyn, New York, and lives in Naples, Florida. Donalds earned a bachelor’s degree in finance and marketing from Florida State University in 2002. His career experience includes working as a commercial credit officer in banking and as a portfolio manager in financial services.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.